| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |